Related Experiment Video
Updated: Oct 3, 2025

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
Published on: August 7, 2021
Megakaryocyte Diversity in Ontogeny, Functions and Cell-Cell Interactions
Eman Khatib-Massalha1,2,3, Simón Méndez-Ferrer1,2,3,4,5
1Wellcome-Medical Research Council (MRC) Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Megakaryocytes (Mks) play diverse roles beyond platelet production, influencing hematopoietic stem cell (HSC) maintenance and immune responses. Understanding Mk diversity is crucial for treating hematologic malignancies and improving stem cell therapies.
Area of Science:
- Hematology
- Cell Biology
- Immunology
Background:
- Hematopoietic stem cells (HSCs) reside in the bone marrow (BM) microenvironment, interacting with stromal and hematopoietic cells for survival, proliferation, and function.
- Megakaryocytes (Mks) are key hematopoietic cells for platelet production (thrombopoiesis) but also influence HSC maintenance and immune responses.
- The diversity in Mk ontogeny, functions, and interactions, particularly in malignant hematopoiesis, is not fully understood.
Purpose of the Study:
- To summarize current knowledge on Mk diversity, ontogeny, functions, and cell-cell interactions.
- To discuss the role of Mks in the onset and progression of bone marrow fibrosis, a complication of hematologic malignancies.
- To highlight the clinical implications of understanding Mk biology for stem cell transplantation and other therapies.
Main Methods:
- This perspective synthesizes existing research and literature.
- It reviews evidence on Mk subpopulations and their functions.
- It discusses the interplay between Mks, HSCs, and immune cells in the BM microenvironment.
Main Results:
- Mks exhibit diverse functions beyond thrombopoiesis, including HSC maintenance and immune modulation.
- Dysfunction of the BM microenvironment, potentially driven by mutated Mks, contributes to hematologic malignancies like myeloproliferative neoplasms (MPNs).
- Abnormal interactions between Mks and immune cells may directly promote fibrotic diseases within the bone marrow.
Conclusions:
- Understanding Mk heterogeneity is vital for comprehending malignant hematopoiesis and BM fibrosis.
- Further research into megakaryopoiesis and Mk interactions with HSCs and immune cells holds significant clinical potential.
- This knowledge can inform therapies for hematologic malignancies, stem cell transplantation, and treatments for thrombocytopenia.
Related Concept Videos
Cell Diversity
Multicellular...
Cellular Differentiation
A zygote is a...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Differentiation of Common Myeloid Progenitor Cells
Multipotency of Hematopoietic Stem Cells
Hematopoiesis

